10
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 257-269 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • A colorimetric estimation of polyethyleneglycol-conjugated phospholipid in stealth lipo- somes. NAG, A., MITRA, G., and Gliosn, P. C., Anal. Biochem., 1997, 250 (1), 35–43.
  • A multiple emulsion method to entrap a lipophilic compound into chitosan microspheres. GENTA, I., PEatadNt, P., Cow], B., and PAvANurn), F., Int. J. Pharm., 1997, 152 (2), 237–246.
  • A novel biodegradable system based on gelatin nanoparticles and poly (lactic-co-glycolic acid) microspheres for protein and peptide drug delivery. Li, J. K., WANG, N., and Wu, X. S., .7. Pharm, Sci., 1997, 86 (8), 891–895.
  • A sol-gel preparation of silica coated zirconia microspheres as chromatographic support materials. SHALLIKER, R. A., Ru,rrouL, L., Dnuui,,ks, G. K., and RUSSELL, S. C., Y. Mater. Sci., 1997, 32 (11), 2949–2955.
  • A theory of erosion and macromolecule release from biodegrading microspheres. BATYCKY, R. II., HANES, J., LANGER, R., and Enn'Aans, D. A., Proc. Int. Syntp. Controlled Release Bioact. Mater., 1997, 24th, 167–168.
  • A tool for balancing activity from isotopes used for the radioactive microsphere method. KLEEN, M., HABLER, 0., and MESSMER, K., C'omput. Methods Programs Blamed., 1997, 53 (2), 81–86.
  • A novel approach to stabilization of protein drugs in poly(lactic-co-glycolic acid) micro- spheres. Li, J. K., WAINI;, N., and Wu, X. S., Polym. Prepr. (Am. Chem. Soc., Div. PoIym. ('hem.), 1997, 38 (2), 604–605.
  • A novel lipid microsphere emulsified by lecithin with saturated fatty acids for prolonged parenteral drug delivery. INotT, T., NAWA, V., TsuTsunnucin, R., 'MAEDA, N., MATSUDA, H., and UEDA, V., Prot-. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 983–984.
  • A polysorbate-based nonionic surfactant improves `beta'-lactoglobulin delivery from PLGA microspheres. FATTAL, E., LH), E., Roms, J., PECQUET, S., and COUVREUR, P., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 597–598.
  • Activity of enzymes immobilized on microspheres with thermosensitive hairs. YASI:I, M., SHIROYA, T., FuJimurn, K., and KAWAGUCHI, 11., Colloids Surf., B, 1997, 8 (6), 311–319. Adsorption of brain proteins on the surface of poly(D,L-lactide-co-glycolide) (PLGA) micro- spheres. SAINI, P., GREENSPAN, P., and Ix, D., Drug Delivery. 1997, 4(2), 129–134.
  • Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice. CONLEY, J., YANG, H., Wit,s()N, T., FILAsErri, K., Di NINNO, V., SCHNELL, G., and WONG, J. P., Antimicroh. Agents Chemother., 1997, 41(6), 1288–1292.
  • Affinity liposomes in vivo: factors influencing target accumulation. Tortclumx, V. P., y. Mol. Recognit., 1996, 9 (5-6), 335–346.
  • Amitogenic alginate-the key to first clinical use of the microencapsulation technology. HASSE, C., KLOC'K, G., ZIELKE, A., BARTH, P., ZIMNIERMANN, U., and ROTHMUND, M., Langenbecks Arch. Chir.Kongressbd., 1997, 114, 755–759.
  • Analysis of cationic liposome-mediated interactions of plasmid DNA with murine and human melanoma cells in vitro. REIMER, D. L., KONG, S., and BALLY, M. B., .7. Biol. Chem., 1997, 272 (31), 19 480–19 487.
  • Analysis of variance of microspheres blood flow measurements in rabbits. Dunm, H. F., RuLo, A. H., ASTIN, M., MAEPEA, 0., VAN DEN BERG, T. J., and GREVE, E. L., Exp. Eye Res., 1997, 64 (4), 545–551.
  • Antineoplastic activity of sterically stabilized alkylphosphocholine liposomes in human breast carcinomas. ARNDT, D., Znstu, R., EuE, I., STERNBERG, B., and FICHTNER, I., Breast Cancer Res. Treat., 1997, 43 (3), 237–246.
  • Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres. AKHTAR, S., and LEWIS, K. J., Int. J. Pharm., 1997, 151 (1), 57–67.
  • Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine pro- drugs. CROSASSO, P., BRUSA, P., Dosio, F., Aaricco, S., PACCHIONI, D., SCHL HER, F., and CAYEEL, L., J. Pharm. Sci., 1997, 86 (7), 832–839.
  • Apoptosis in phagocytotic cells of lymphoid tissues in rainbow trout (Oncorhynchus mykiss) following administration of clodronate liposomes. ESPENES, A., PRESS, C. M., ROOIJEN, N. V., and LANDSVERK, T., Cell Tissue Res., 1997, 289 (2), 323–331. 0265-2048/98 812–001998 Taylor & Francis Ltd.
  • Application of long-circulating liposomes to cancer photodynamic therapy. OKU, N., SAITO, N., NAMBA, Y., TstIKADA, H., DOLPHIN, D., and OSADA, S., Biol. Pharm. Bull., 1997, 20 (6), 670–673.
  • Assembly of protein structures on liposomes by non-specific and specific interactions. VELEV, 0. D., Adv. Biophys., 1997, 34, 139–157.
  • Assessment of insulin secretion in vitro from microencapsulated fetal porcine islet-like cell clusters, and rat, mouse, and human pancreatic islets. SANDLER, S., ANDERSSON, A., EIZIRIK, D. L., HELLERS'ERDEM, C., ESPEVIK, T., KULSENG, B., THU, B., PIPELEERS, D. G., and SKJAAK, B. G., Transplantation, 1997, 63 (12), 1712–1718.
  • Assimilation of gelatin-acacia microencapsulated lipid by Pacific oyster (Crassostrea gigas) spat. KNAUER, J., and SOUTHGATE, P. C., Aquaculture, 1997, 153 (3,4), 291–300.
  • Association and release of prostaglandin El from liposomes. DAVIDSON, S. M., CABRAL, L. D., MAURIO, F. P., FRANKLIN, J. C., MINCHEY, S. R., AHI., P. L., and JANoFF, A. S., Biochim. Biophys. Acta, 1997, 1327 (1), 97–106.
  • Bioadhesive microspheres for increased bioavailability. MATHIONVITZ, E., CARING, G. P., JA( J. S., JoNG, Y. S., SANTos, C., and CHICKERING, D. E. III., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 15–16.
  • Bioadhesive microspheres: HI. An in vivo transit and bioavailability study of drug-loaded alginate and poly(fumaric-co-sebacic anhydride) microspheres. CHICKERING, D. E. III, JACOB, J. S., DESAI, T. A., HARRISON, M., HARRIS, W. P., M0RRF.1.1., C. N., CHATURVEDI, P., and MATYnown-z, E., y. Controlled Release, 1997, 48 (1), 35–46.
  • Biodegradable microspheres of gentamicin sulfate. PANDEY, S., MAJUNIDER, M., SINGH, U. V., and UDUPA, N., Indian y. Pharm. Sci., 1997, 59 (2), 81–85.
  • Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(- ethyleneglycol)s. SHIMADA, K., KAMPS, J. A., RECITS, J., IKEDA, K., SnoiZAWA, T., HIROTA, S., and SCHERPHOF, G., Biochim. Biophys. Acta, 1997, 1326 (2), 329–341.
  • Biological activity of lysozyme after entrapment in poly(DL-lactide-co-glycolide) micro- spheres. GHADERI, R., and CARLFORS, J., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 253–254.
  • Cationic liposome-mediated uptake of human immunodeficiency virus type 1 Tat protein into cells. For, :c, S. E., SNIANIK, P., SMITH, M. C., and JASKUNAS, S. R., y. Virol. Methods, 1997, 66(1), 149–157.
  • Cellular and humoral responses to microencapsulated Yersinia pestis subunit vaccines following oral delivery. SHARP, G. J., EYLEs, J. E., WILLIAMSON, E. D., BROWN, M. R. W., and OVA, A. H., Biochem. Soc. Trans., 1997, 25 (2), 338S.
  • Changes in cholinergic neurons and failure in learning function after microsphere embol- ism-induced cerebral ischemia. TAKAGI, N., MIYAKE, K., TAGUCHI, T., St,GITA, N., TAKAGI, K., TANIADA, H., and TAKEO, S., Brain Res. Bull., 1997, 43 (1), 87–92.
  • Chitosan and methylpyrrolidinone chitosan microspheres. GENTA, I., Gil'NCI-IEnt, P., CONTI, B., MUZZARELLI, R. A. A., and CoNTE, U., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 999–1000.
  • Coacervate microspheres as vaccination vehicles. AZHARI, R., DANINO, E., KAst-ro, H., KUSHNIR, A., KOTLIAREVSKI, L., and LEVIN, D., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 821–822.
  • Collection of fluorescence from single molecules in microspheres: effects of illumination geometry. Him., S. C., BARNES, M. D., WHITTEN, W. B., and RAMSEY, J. M., Appl. Opt., 1997, 36 (19), 4425–4437.
  • Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy. 13RtiNo, M. J., BoRm, J. J., Hon, F. J., DELZENNE, B., HOFMANN, A. F., DE GOEIJ, J. J., VAN ROYEN, E. A., VAN GULIK, T. M., DE WIT, L. T., GOUMA, D. J., VAN LEEUWEN, D. J., and TYTGAT, G. N., Br. Surg., 1997, 84(7), 952–956.
  • Comparative topical anaesthesia of EMLA and liposome-encapsulated tetracaine. HUNG, 0. R., COMEAU, L., RILEY, M. R., TAN, S., WFIYNOT, S., and MEZEI, M., Can. ..7. Anaesth., 1997, 44 (7), 707–711.
  • Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: inhibition by soluble complement receptor type 1. SzEBEN:, J., SPIELBERG, H., CLIFF, R. 0., WASSEF, N. M., RUDOLPH, A. S., and ALVING, C. R., Artif. Cells Blood Substit. Immobil. Biotechnol., 1997, 25 (4), 347–355.
  • Contraceptive efficacy of norethindrone encapsulated in injectable biodegradable poly-dl- lactide-co-glycolide microspheres (NET-90): phase III clinical study. SINGH, M., SAXENA, B. B., SINGH, R., KAPLAN, J., and LEDGER, W. J., Adv. Contracept., 1997, 13(1), 1–11.
  • Contribution of trypsin-sensitive proteins to binding of cationic liposomes to the mouse macrophage-like cell line RAW264.7. AMNIA, H., ARAMAKI, Y., and TSUCHIYA, S., y. Pharm. Sci., 1997, 86 (7), 786–790.
  • Controlled release of aldicarb from carboxylmethyl cellulose microcapsules.lc:A, M. Y., YiGiToGi.1, NI.,\LE, Ni., KOK, F. N., and 1-1Asiaci, V., Turk. J. Chem., 1997, 21(2), 100-104. Controlled release of FITC-BSA from polymer coated gelatin microspheres. RA(), J. K., and RAD, K., y. Bioact. Contpat. Polym., 1997, 12 (2), 127–139.
  • Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co- imide) microspheres. CIIIBA, M., HANES, J., and LANGER, R., Biomaterials, 1997, 18 (13), 893–901.
  • Controlled release of BSA from biodegradable PLA and MPOE-PLA microspheres. BouiLiArr, P., 015E1., R., and DELA:M:11E151E, E., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 955–956.
  • Craniofacial and TMJ effects after glutamate and TRH microsphere implantation in proxi- mity to trigeminal motoneurons of growing rats. BYRD, E., SuKAY, NI. J., DIETERLE, NI. W., YANG, L., MARTING, T. c., TEomiN, D., and Donut, A. L./. Dent. Res., 1997, 76(8), 1437–1452.
  • CW laser oscillation on both the 4F3/2-4111/2 and 4F3/2-4I13/2 transitions of Nd3 + ions using a fluoride glass microsphere. MIURA, K., TANAKA, K., and HIRAO, K., J. Non-Cryst. Solids, 1997, 213/214, 276–280.
  • Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF, and TNF-alpha show improved pharmacokinetics, and biological activity and reduced toxicity in mice. KEDAR, E., PALGI, 0., 001.0D, G., BABAI, I., and BARENHOLZ, Y., J. Immunother., 1997, 20 (3), 180–193.
  • Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid. GUPTA, R. K., CHANG, A. C., GairFiN, P., RIVERA, R., Guo, Y. Y., and SIBER, G. R., Vaccine, 1997, 15 (6/7), 672–678.
  • Determination of structure and properties of polyurethaneurea microcapsules. I ciiIKANVA, K., Kohunshi Kako, 1997, 46 (5), 217–223.
  • Development of multiparticulate-system composed of sustained-release microspheres of pseudoephedrine hydrochloride and immediate-release pellets of terfenadine using solvent evaporation method and spherically agglomerated crystallization. RHEE, G. J., Do, K. C., Kim, E. H., PARK, J. B., and WHANG, S. J., Yakhak Hoechi, 1997, 41(3), 305–311.
  • Development of biocompatible barium alginate microcapsules. PETauzzo, P., CAPPAI, A., Ruiu, G., 1)Fssr, E., REsciGNo, A., and BaoTzt., G., Transplant Proc., 1997, 29 (4), 2129–2130.
  • Development of microcapsule for latent heat transportation. TANAKA, NI., Kemikaru Enjiniyar-ingu, 1997, 42 (7), 521–527.
  • Development of novel drug delivery system of bioactive molecules from `cytomedicine' using hybridoma cells entrapped in alginate-poly(L-lysine)-alginate microcapsules. YOSHIOKA, T., OKADA, N., MiyAmoTo, H., SAKANIOTO, K., KATSUME, A., SAITO, H., YOROZU, K., UEDA, 0., NAKAGAWA, S., et at., Drug Delivery Syst., 1997, 12 (2), 107–114.
  • Dielectric and thermodynamic properties of biodegradable poly(DL-lactide-co-glycolide) and the effect on the microencapsulation and release of captopril. SC'HARTEL, B., \TOLLAND, C., Li, Y. X., WENDORFF, J. W., and KissEi., T., .7. Microencapsulation, 1997, 14 (4), 475–488.
  • Different intrahepatic distribution of phosphatidylglycerol and phosphatidylserine liposomes in the rat. DAEN1EN, T., VELINovA, M., REGTs, J., DE JAGER, M., KALICHARAN, R., DONGA, J., VAN 01:15 WANT, J. J., and ticirrimior, G. L., Hepatology, 1997, 26 (2), 416–423.
  • Diffusion-controlled formation of husk-like microcapsules. SAKURAZAWA, S., ISIIINIOR1, T., HoNDA, H., and N1ATsuNo, K., Colloid Polym. Sci., 1997, 275 (5), 502–525.
  • Drug targeting with liposome encapsulated 5-FU. Pharmacokinetics of i.v. and locoregional therapy-an animal experiment study with VX-2 liver tumor. BERGER, G., POHLEN, JUNG, Ni., RESZK \, R., PALISER, S., and B511111, H. J., Langenbecks Arch. Chir. Suppl. Kongressbd, 1997, 114, 127–130.
  • Drug properties and release from CAP microcapsules. FERREIRA, J. P., PEGO, A., and SII.VA, P. S., Proc. Int. Snip. Controlled Release Bioact. Mater., 1997, 24th, 353–354.
  • Dynamic swelling behavior of gelatin/poly(acrylic acid) bioadhesive microspheres loaded with oxprenolol. LEUCUTA, S. E., PONCHEL, G., and DUCHENE,Microencapsulation, 1997, 14 (4), 501–510.
  • Effect of membrane modification by PEG on prolongation of circulation time of liposomes in blood in vivo. Flou, X. P., ZHANG, J. NI., and Lu, X. D., Yao Hsueh Hstteh Pao, 1996, 31(6), 451–454.
  • Effect of liposome-encapsulated hemoglobin on triglyceride, total cholesterol, low-density lipoprotein, and high-density lipoprotein cholesterol measurements. Aisout.LAH, F., WHITEFoan, NI., MA'I'llIAK, G., OvAniA, P., Runoi.m, A., NEVILLE, L. F., and RABIN0VIC1, R., Lipids, 1997, 32 (4), 377–381.
  • Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide. V wcAao, A. NI., TATI'l, Ni., CIAFFONI, F., SALV101,1, R., BARCA, A., and SCERCH, C., 1. Biol. Chem., 1997, 272 (27), 16 862–16 867.
  • Effect of surface treatment on the respirable fractions of PLGA microspheres formulated for dry powder inhalers. PHILIP, V. A., MEHTA, R. C., MAZUNIDER, M. K., and DELEcA, P. P., hit. y. Pharm., 1997, 151 (2), 165–174.
  • Effect of ultraviolet light on the release of theophylline from ethylcellulose-based sustained- release microcapsules. ASKER, A. F., and FEaDous, A. J., PDA J. Pharm. Sci. Technol., 1997, 51(3), 125–129.
  • Effect of IL-1 receptor antagonist included microencapsulated islets to damage of islet cells by IL-1.beta. KANEDA, T., YAMASHI'l'A, T., OHIRA, M., ISHIKAWA, T., TAKEUCHI, K., YANAGAWA, K., YADA, K., SowA, M., and IWATA, H., Igaki no Ayumi, 1997, 182 (2), 159–160.
  • Effect of liposome encapsulated hemoglobin 'neo red cells' on severe hemorrhagic shock. USUBA, A., and MoToEt, R., Artif. Cells Blood Sztbstit. Immobil. Biotechnol., 1997, 25 (4), 379–392.
  • Effect of PLGA end groups on encapsulation and release of tobramycin from microspheres produced by organic processes. VAN HANIONT, J. E., JEYANTIII, R., BARsount, I., and RACLIN, L. A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 885–886.
  • Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes. EDWARDS, K., JonNssoN, M., KARLSSON, G., and StI.V\NDER, M., Biophys. y., 1997, 73 (1), 258–266.
  • Effects of alginate/polyaminoacidic coherent microcapsule transplantation in adult pigs. CALAFIORE, R., BASTA, G., BosEE1.1, C., BUFALARI, A., Gn.7sTozzt, G. M., LUCA, G., Toirrotot.t, C., and BRUNETTI, P., Transplant Proc., 1997, 29 (4), 2126–2127.
  • Effects of fluctose-1,6-biphosphate on microsphere-induced cerebral ischemia in the rat. TRINIARC'HI, G. R., ARCADI, F. A., IMPERATORE, C., RUDDER, P., and COSTA, G., Life Sri., 1997, 61 (6), 611–622.
  • Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats. TAKEO, S., HAYASHI, H., MIYAKE, K., TAKAGI, K., TAookoao, M., TAKAGI, N., and OSIIIKAWA, S., Br. J. Pharmacol., 1997, 121 (3), 477–484.
  • Encapsulation of cytochrome C by multilayer microcapsules. A model for improved enzyme immobilization. Rn.t.[NG, P., WALTER, T., POMMERSHEIM, R., and VOGT, W., J. Membr. Sci., 1997, 129 (2), 283–287.
  • Encapsulation of oligonucleotides in polylactide microspheres. FREYTAG, T., DASHEVSKY, A., MEHTA, R., HARDEE, G. E., and BODMEIER, R., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 657–658.
  • Encapsulation, stability and in vitro release characteristics of liposomal formulations of colchicine. KULKARNI, S. B., SINGH, M., and BETAGERI, G. V., J. Pharm. Pharmacol., 1997, 49 (5), 491–495.
  • Enteric cellulosic microspheres for taste-masking of cefuroxime axetil: stability and in vitro release behavior. CUNA, M., LORENZO, M. L., VII.A JATO, J. L., TotutEs, D., and AEoNso, M. J., Acta Technol. Legis. Med., 1996, 7 (3), 209–216.
  • Evaluation of intratumoral injection of poly(dl-lactide) cisplatin microspheres in rats with breast tumors using (131I)iodomisonidazole (IMISO). YANG, D. J., KUANG, L., INOUE, T., CHERIE', A., WRIGHT, K. C., TANSEY, W., LIU, C. W., WALLACE, S., KIN, E. E., and P000t.orr, D. A., Drug Delivery, 1997, 4 (2), 107–113.
  • Evaluation of the microenvironment inside biodegradable microspheres from ABA triblock copolymers of poly(1-lactide-co-glycolide) and poly (ethylene oxide) prepared by spray drying. BITTNER, B., MAEDER, K., Li, Y. X., and KISSEL, T., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 535–536.
  • Experimental bronchiolitis obliterans induced by in vivo HVJ-liposome-mediated endothe- lin-1 gene transfer. TAKE:DA, S., SAWA, Y., MINAMI, M., KANEDA, Y., FUJII, Y., SHIRAKURA, R., YANAGISAWA, M., and MATSUDA, H., Ann. Thorac. Surg., 1997, 63 (6), 1562–1567.
  • Experimental study of preparation of agarose bioartiflcial microcapsules. Yu, D., GAO, W., YIN, W., Wu, R., and YAO, K., Zhonghua Neifenmi Daixie Zazhi, 1996, 12 (4), 218–221.
  • Extended release of adenovirus from polymer microspheres: potential use in gene therapy for brain tumors. BEER, S. J., HIFINGER, J. M., and DAVIDSON, B. L., Adv. Drug Delivery Rev., 1997, 27(1), 59–66.
  • Extradural bupivacaine-loaded microspheres and spinal cord blood flow in the chronically instrumented rabbit. MALINOVSKY, J. M., BERNARD, J. M., LE CORRE, P., FAIVRE, A., CHATAL, J. F., and PINAUD, M., Clin. Physiol., 1997, 17 (4), 361–370.
  • Factors Affecting the In Vitro Release of Recombinant Human Interferon-gamma (rhIFN- .gamma.) from PLGA Microspheres. YANG, J., and CLELAND, J. L. J. Pharm. Sci., 1997. 86 (8), 908–914.
  • Failure in learning task and loss of cortical cholinergic fibers in Microsphere-embolized rats. TAKAGI, N., MIYAKE, K., TAGUCHI, T., TAMADA, H., TAKAGI, K., SUCITA, N., and TAKE°, S., Exp. Brain Res., 1997, 114 (2), 279–287.
  • Fatty acid substituted poly(vinyl alcohol)s. Proposal for a new polymer suitable for bio- degradable microspheres. ORIENT, 1., .AIEtwii, K., and acciii, V., Proc. Int. Symp. Controlled l?elease Biotin'. Mater., 1997, 24th, 495–496.
  • Ferrite-capsulated porous silica microspheres for ultrasonic contrast agents. ZIIANG, KrrAmoTo, Y., and Alit:, M., .7. Phys. IV, 1997, 7 (Cl, 7th International Conference on Ferrites, 1996), C1/669-C1670.
  • Fluorescent labeled peptides as a useful tool for characterization of microsphere drug delivery systems. BRENNER, A., and C;0EPEERIcii, A., Proc. Int. Symp. Controlled Release Bioart. Mater., 1997, 24th, 903–904.
  • Formulation and evaluation of chlorpromazine hydrochloride loaded self-crosslinked gela- tin microcapsules. S \ MANTA, NI. K., Thio.v.vs.vs, S., BARU, K., and SI•RESII, B., Indian y. Pharm. Sri., 1997, 59 (2), 68–74.
  • Formulation characteristics of ofloxacin microspheres for treatment of osteomyelitis. Owl su, A. (i., 07svAl.troit, S., HARni, NI., andN. K., Proc. Int. Symp. Controlled Release Bioart.Maier., 1997, 24th, 783–784.
  • Gene transfection by cationic liposomes: comparison of the transfection efficiency of liposomes prepared from various positively charged lipids. ZHAO, D. D., WATAR.0, S., LEE, J. T., Kot•ein, S., ()Immo, H., and YAst.DA, T., Acta. Med. Okayama, 1997, 51(3), 149–154.
  • Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene. AoKi, K., YostilnA, T., M VESE NIDTD, N., 11., HosokAw, K., St'iiimuRA, T., and TE.RADA, M., Hum. Gene Titer.,1997, 8 (9), 1105–1113.
  • Gene therapy for central nervous system injury: the use of cationic liposomes: an invited review. Y \s,e, K., CurroN, G. L., and HAYEs, R. L., .7. Neurotraunta, 1997, 14 (5), 281–297. 118 Refs.
  • Heparin loaded PLGA-microspheres for inhibition of human vascular smooth muscle cell proliferation. BIRKENILAUER, P., YA:sii, Z., CIIK KERING, D. E., RANIERI, J., LuscilER, T. F., NIERKLE, II. P., and G \ NDER, B., Proc. Int. Symp. Controlled Release Biotin'. Mater., 1997, 24th, 951–952.
  • Hollow microspheres from polyethylene terephthalate. DoRoGoTovrsEv, V. NI., AKI NETS, A. A., and NIERKI 1.1E‘, Y. A., Fusion Tee/tool., 1997, 31(4), 468–472.
  • Hydrolytic degradation of blank and drug loaded poly-a-hydroxy acid microspheres. CHI NCIIEDI, P., envri, II., ScALIA, S., ScAyruitiN, A., and CovrE, U., Proc. Int. Symp. Controlled Release Biotin. Mater., 1997, 24th, 997–998.
  • Hydrothermal light-weight calcium phosphate cements: use of polyacrylonitrile-shelled hollow microspheres. Sl.(IANIA, T., and Liewitn,Mater. Sri., 1997, 32 (13), 3523-3534.Hyperthermia potentiates antitumor effect of thermosensitive-liposome-encapsulated mel- phalan and radiation in murine melanoma. CHELVI, '1'. P., and RALIIAN, R., Tumour Biol., 1997, 18 (4), 250–260.
  • Immunological responses following oral and intra-muscular administration of PLA micro- spheres manufactured using surfactants with adjuvant properties. Al-PAR, II. 0., J., PYLES, J. E., and NVII.1.1ANisoN, E. D., Proc. Int. Situp. Controlled Release Bioact. Mater., 1997, 24th, 785–786.
  • Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. SPRAGG, D. D., AixoRD, D. R., GitrElick En, R., LARsEs:, C. E., LEE, K. D., GuRTNER, G. C., CYBELSKY, NI. I., Tics, P. F., Non,,',,, C., and GiNiiiRiesE, NI. A. JR., Proc. Natl. Acad. Sci. USA., 1997, 94 (16), 8795–8800.
  • Importance of sebaceous glands in cutaneous penetration of an antiandrogen: target effect of liposomes. BEit Aim, E., DuBois, J. L., and NVEPIERRE, J.,Pharrn. Sci., 1997, 86 (5), 573-578.Improved activity of a new angiotensin receptor antagonist by an injectable spray-dried polymer microsphere preparation. LAEASSFI, F. X., IIII.nuEN, P.., PERonix, J., ESCIIER, E., PHILLIPS, N. C., and AlleNI0.i.rs, J. N., Pharm. Res., 1997, 14 (7), 887–891.
  • Improved DNA: liposome complexes for increased systemic delivery and gene expression. TrAii, LET(N, N. S., LAsic, D. D., FEnERIK, P. \lH. H. H., 'bawler's, D. D., and PAvi.AKis,G. N., Vol. Biotechnol., 1997, 15 (7), 647–652.
  • In vivo evaluation of zidovudine (AZT)-loaded ethylcellulose microspheres after oral admin- istration in beagle dogs. Anil IZZA, K., TANIIIR11.1.D, L., and Li', D. R., y. Pharm. Sri., 1997, 86 (5), 554–559.
  • In vitro and in vivo release kinetics of a somatostatin analog from PLGA microspheres. BIANco, P. NI. J., ORsol.rsi, P., HEIMGARTNER, F., BESSEGIIIR, K., MARKLE, H. P., and G kNDER, B., Proc. Int. Symp. Controlled Release Biotin'. Mater., 1997, 24th, 953–954.
  • In vitro characterization of methotrexate loaded poly(lactic-co-glycolic) acid microspheres and antitumor efficacy in Sarcoma-180 mice bearing tumor. SINGH, U. V., and UDUPA, N., ['harm. Ac to Hely., 1997, 72 (3), 165–173.
  • In vitro degradation of serum albumin microcapsules: effect of process variables. ANDsr, M. C., and Levy, M. C., Int.Pharm., 1997, 152(2), 145–151.
  • In vitro-in vivo correlation of oral sustained release ibuprofen microspheres. JANJIKI1EL, R. K., and ADENTYE, C. M., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 293–294.
  • In vitro and in vivo respirable fractions of isopropanol treated PLGA microspheres using a dry powder inhaler. PHII,IP, V. A., MEHTA, R. C., and DELucA, P. P., Int. j. Pharm., 1997, 151 (2), 175–182.
  • In vitro degradation kinetics of PLA /PLGA microspheres and films: the role played by buffer salts. REICH, G., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 175–176.
  • In-vivo and in-vitro degradation of poly(lactide-co-glycolide) microspheres. TRACY, M. A., ZHANG, Y., VERDON, S. L., DoNG, N., and RH,Ev, M. G. I., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 623–624.
  • Increased efficacy of aphidicolin killing of human neuroblastoma cells in vitro by encapsu- lation in liposomes. CINATL, J. JR., HERNAIZ DRIEVER, P., CINATL, J., RUCKERT, D. G., GUMMI., H. 0., RARENAU, H., KORNHUBER, B., and DOERR, H. W., Neoplasma, 1997, 44 (2), 91–95.
  • Increased sciatic nerve blood flow in diabetic rats: assessment by 'molecular' vs. particulate microspheres. CHANG, K., 11)0, Y., LEJEuNE, W., WILLIANISON, J. R., and Tn,ToN, R. G., Am. 1. Physiol., 1997, 273(1 Pt 1), E164–E173.
  • Influence of the production method on protein adsorption of biodegradable microspheres. LUECK, M., PISTEL, K. F., Kissn, T., and MUELLER, R. H., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 937–938.
  • Influence of size, dosage, and surface structure on clearance and tissue distribution of intravenous microspheres. GAO, Q. P., HANSEN, B., and SELJELID, R., Drug. Delivery, 1997, 4 (2), 93–99.
  • Influence of the properties of the furnace atmosphere on microsphere quality. Dorm( ;oil A-rsEv, V. M., and AKUNETS, A. A., Fusion Technol., 1997, 31(4), 411–417.
  • Inhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease. PRETZER, E., FLASHER, D., and DUZGUNECS, N., Antiviral Res., 1997, 34 (1), 1–15.
  • Interaction of alpha s2- and beta-casein signal peptides with DMPC and DMPG liposomes. CREUZENET, C., DURAND, C., and HAERTLE, T., Peptides, 1997, 18 (4), 463–472.
  • Interaction of polyethyleneglycol coated liposomes and plain liposomes studied using fluorescent probes. POLO, D., HARO, I., At.sINA, M. A.., and REIC;, F., Biomed.-Chromatogr., 1997, 11(2), 75–76.
  • Interstitial MR lymphography using Gd-carrying liposomes. MIssEi,wrrz, B., and SACHSE, A., Acta. Radiol. Suppl., 1997, 412, 51–55.
  • Intraperitoneal administration of 5-fluorouracil microspheres against peritoneal carcinoma- tosis in rodents. YAMASAKI, J., HAGIWARA, A., TAKAHASHI, T., MURANISHI, S., and 1K:um, Y., Drug Delivery Syst., 1997, 12 (2), 95–100.
  • Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes. HARASYM, T. 0., Cul.[As, P. R., and RALLN, M. B., Cancer Chemother. Pharmacol., 1997, 40 (4), 309–317.
  • Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer. NomtiaA, T., NAKAHMA, S., KAWABATA, K., YAMASHITA, F., TAKAKURA, Y., and HASHIDA, M., Cancer Res., 1997, 57 (13), 2681–2686.
  • Karate CS insecticide, a novel microencapsulated formulation. MARTIN, S. H., MINK, J. S., and BoYKIN, R. S., Proc. Beltwide Cotton Conf., 1997, 1, 50–51.
  • Kinetic aspects of polyelectrolyte adsorption: adsorption of chitin derivatives onto liposomes as a model system. MosED, M., and CHANG, T. M., Artif. Cells Blood Sithstit. Immobil. Biotechnol., 1997, 25 (4), 367–377.
  • Linkup of a fast protein liquid chromatography system with a stirred thermostated cell for sterile preparation of liposomes by the proliposome-liposome method: application to encapsulation of antibiotics, synthetic peptide. TURANEK, J., ZAI,t7sKA, D., and NEcA, J Anal. Biochem., 1997, 249 (2), 131–139.
  • Liposomal amphotericin (AmBisome) is safe in bone marrow transplantation for primary immunodeficiency. PAsic, S., FLANNAGAN, L., and CANT, A. J., Bone Marrow Transplant, 1997, 19(12), 1229–1232.
  • Liposomal 1,25 (OH)2 vitamin D3 compounds block proliferation and induce differentiation in myelomonocytic leukaemia cells. FRANKENBERGER, M., HOFMANN, B., ENIMERICII, B., NERL, C., SCHWENDENER, R. A., and ZIEGLER HErraaocK, H. W., Br. y. Haematol., 1997, 98 (1), 186–194.
  • Liposomal amphotericin B and recombinant human granulocyte-macrophage colony-stimu-lating factor (rHuGM-CSF) in the treatment of paediatric AIDS-related cryptococcosis. MANIFREUI, R., Gatos;Roo, 0. V., MASTROIANNI, A., and CHIODO, F., Int. 1. STD AIDS, 1997, 8 (6), 406–408.
  • Liposomal targeting of bc1-3 antisense oligonucleotides with enhanced stability into human myeloma cell lines. OLLIKAINEN, H., LAPPALAINF:N, K., JAASKELAINEN, I., SYRJANEN, S., and PITKKI, K., Leuk. Lymphoma, 1996, 24 (1-2), 165–174.
  • Liposome encapsulation attenuates hemoglobin-induced vasoconstriction in rabbit arterial segments. Runoi.rii, A. S., Sui.pizio, A., HiEBEE, P., MAcDoNALD, V., CHAVEZ, M., and FEt-EasTEIN, G., j. Appl. Physiol., 1997, 82 (6), 1826–1835.
  • Liposome-encapsulated ampicillin: physicochemical and antibacterial properties. SCHUMACHER, I., and MARGALIT, R., Y. Pharm. Sci., 1997, 86 (5), 635–641.
  • Liposomes and immunoassays. RoKGEN, H. A., BULT, A., and VAN BENNEI«)M, W. P., Immunol. Methods, 1997, 204 (2), 105–133.
  • Liposomes as drug delivery vehicles for boron agents. HAtATItoKNE, M. F., and SHELLY, K., 7. Neurooncol., 1997, 33 (1–2), 53–58.
  • Liposomes for drug targeting in the lymphatic system. HIRNLE, P., Hybridoma, 1997, 16(1), 127–132.
  • Liposomes-coated hydroxyapatite and tricalcium phosphate implanted in the mandibular bony defect of miniature swine. HANG, J. S., Liu, K. M., CHEN, C. C., Ho, K. Y., Wu, Y. M., WANG, C. C., CHENG, Y. M., Ku, W. L., Liu, C. S., Ho, Y. P., WANG, Y. P., and HONG, K., Kau FishingKo Hsueh Tsa Club, 1997, 13 (4), 213–228.
  • Localization of enzymically enhanced heavy metal accumulation by Citrobacter sp. and metal accumulation in vitro by liposomes containing entrapped enzyme. JEONG, B. C., HAwEs, C., BoNTiiRoNE, K. M., and MACASKIE, L. E., Microbiology, 1997, 143 (7), 2497–2507.
  • Long-term immune response in mice following subcutaneous administration of BSA-PLGA microspheres. PEDKAz, J. L., IGARTuA, M., HERNANDEZ, R. M., ESQUISABEL, A., GASCON, A. R., and CAIN°, B., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 879–880.
  • Manufacturing of precise microspheres and their application fields. BRANDAU, T. E., Chem. Tech. (Heidelberg), 1997, 26 (5), 120, 122–123.
  • Mechanism of drug release from silicone microspheres containing Polycarbophil. CARELIA, V., DI COLO, G., GESI, M., MARTINI, F., and NANNIPIERI, E., Int. 7. Pharm., 1997, 153 (1), 105–114.
  • Mechanism of the interaction of hydrophobically-modified poly-(N-isopropylacrylamides) with liposomes. Poi,ozovA, A., and WINNIK, F. M., Bioehim. Biophys. Acta, 1997, 1326 (2), 213–224.
  • Mechanisms of vasodilation elicited by VIP in sterically stabilized liposomes in vivo. SEtouitNE, F., Suzum, H., ALKAN ONYUKSEI„ H., G.Ao, X. P., IKEZAKI, H., and RUBINSTEIN, J., Am. J. Physiol., 1997, 273 (1 Pt 2), R287–R292.
  • Metronidazole microencapsulation into biodegradable poly(lactide-co-glycolide) copoly- mers. VooK, N., VAN HAMONT, J., LI tioNG, H., HOLLAND, L., RAVIZEE, A., and Woon, B., Proc. Int. Symp. Controlled Release Blond. Mater., 1997, 24th, 1051–1052.
  • Microencapsulated command formulations in cotton. Sims, B. D., STRINGER, S. J., I -I. R., MIZE, 'I'. W., and GAGE, E. V., Prot-. Beltzvide Cotton ('on., 1997, 1, 791–793.
  • Microencapsulation and fractal characterization of ultramarine particles. YANG, G., Cui, J., 'IAN, L., Vi., M., ZHANG, W., and MA, F., Guisuanyan Xuebao, 1997, 25 (1), 66–71.
  • Microencapsulation of olvanil using 50:50 poly(di-lactide-co-glycolide) using solvent eva- poration processes. PAK, S. J., DuoNG, H., GAi.i.owAv, R., Wool), B. A., VOOK, N., and VAN I AMONT, J. E., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 639–640. Microencapsulation of cefazolin using 50:50 poly(DL-lactide-co-glycolide) as polymeric excipient using solvent extraction processes. PAK, S. J., DUONG, H., Wool), B. A., VooK, N., VAN HARNIONT, J. E., and RAULIN, L. A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 967–968.
  • Microencapsulation of pharmaceuticals by fluidized bed process. Apparatus, material and particulate designs. FuNtimoRt, Y., and Ictin:AwA, H., Funtai Kogaku Kaishi, 1997, 34 (7), 536–544.
  • Microencapsulation of recombinant humanized monoclonal antibody for local delivery. LAAi, X. M., DITENAs, E. T., and CLELAND, J. L., Prot-. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 759–760.
  • Microencapsulation of antigens using biodegradable polyesters. Facts and Phantasies. KissEi., T., KoNEBERG, R., HILBERT, A. K., and HUNGERER, K. D., Behring Inst. Mitt., 1997, 98 (New Approaches to Bacterial Vaccine Development), 172–183.
  • Microencapsulation of lead chrome yellow and characterization of the surface shape. YANG, G., VAN, L., Cri, J., SONG, Y., ZIIANG, W., and Gut), C., Yingyong Huasue, 1997, 14(3), 1–4.
  • Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microspheres. SAII, H. J. Controlled Release, 1997, 47 (3), 233–245.
  • Microencapsulation by surfactant-gelatin insoluble complex: effect of pH and surfactant concentration. VINETSKY, Y., and MAGDASS1, s., J. Colloid Interface Sci., 1997, 189(1), 83–91.
  • Microencapsulation of ultramarine particles in water/oil emulsion and surface fractal dimensionality of the particles. (it'lutN, Y., XiAozENG, L., LEmn, Y., DANzlioNG, C., and CONGRONG, G., Dyes Pigm., 1997, 34 (1), 57–62.
  • Microscopic observation of filtration of fluorescent polymer microspheres in a bed of cellulose fibers under acidic and alkaline conditions. CHASE, G. G., JouNsoN, T., BOYAR:NT, R. J., and OTT, D. W Fluid/Part Sep. y., 1997, 10 (1), 28–36.
  • Microsphere synthesis by dispersion coplymerization of methyl methacrylate with poly(- crylic acid) macromonomers. pH effect on microsphere formation. Isinzu, K., IANIA HITA, M., and IciumtutA, A., Macromol. Rapid Commun., 1997, 18 (8), 639–642.
  • Microsphere formulation characteristics of a modified hydrophobic (L-lactide) polymer. TANI111111, H., NIERKLE, H. P., and GANDER, B., Proc. Int. Symp. Controlled Release Blood. Mater., 1997, 24th, 989–990.
  • Microspheres with 125I-iodo-deoxyuridine for controlled delivery to the brain. REZA, NI. S., and WHATELEY, T. L., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 787–788. Microspheres as a drug delivery system for tropicamide. DURRANI, A. M., KELLAWAY, I. W.,Mitoxantrone-loaded albumin microspheres for intraperitoneal chemotherapy. IA FTEN - STEINER, C. P., VIERNSTEIN, H., SCHWEN DENWEIN, 1., and Eicin.r.it, H. C., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 451–452.
  • Modifications in high-density lipoprotein lipid composition and structure alter the plasma distribution of free and liposomal annamycin. WASAN, K. M., NG, S., and CAssu)Y, S. NI., y. Pharm. Sci., 1997, 86 (7), 872–875.
  • Modified release ibuprofen-Eudragit RS 100 microspheres: the influence of dissolution variables and topographical evaluation. DANGOR, C. M., PERI:MAI., D., MooPANAR, K. R., fluaBANs, N., LE Roux, C., and ESSACKS, S. Y., Proc. Int. Symp. Controlled Release &octet. Mater., 1997, 24th, 357–358.
  • Modulated release profiles of IdUrd from poly(D,L-lactide-co-glycolide) microspheres by addition of poly(D,L lactide) oligomers. Grit, A., VENIER, J. M. C., DAUNIAS, D. C., DEVAUCHELLE, P., and BExort, J. P., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 993–994.
  • Morphological changes induced by phospholipase C and by sphingomyelinase on large unilamellar vesicles: a cryotransmission electron microscopy study of liposome fusion. BASANEZ, G., Rtu AituLJELI,o, NI. B., ALoNso, A., Gom, F. NI., KARLSSON, G., and EDWARDS, K., Biophys. y., 1997, 72 (6), 2630–2637.
  • Morphology dependent resonances of microspheres and spontaneous emission of dye molecules. Bistur, P. B., FIJKLIDA, K., and HIRAYANIA, S., Proc. SPIE-Int. Soc. Opt. Eng., 1997, 2980 (Advances in Fluorescence Sensing Technology III), 434–445.
  • Mucoadhesive microspheres for local antibiotic therapy. FERRARI, F., Rosso, S., BoxrEitom, NI. C., CloccA, C., and CARANIELLA, C., Proc, ha. Symp. Controlled Release Bioact. Mater., 1997, 24th, 249–250.
  • Multivalent ligand system carrying enkephalin and neurotensin coimmobilized on lipo- somes. Ziim), J., KIMURA, S., and INIANISIII, Y., J. Pep.. Sci., 1996, 2 (4), 245–251.
  • New sorbents for removal of heavy metal ions: diamine-glow-discharge treated poly- hydroxyethylmethacrylate microspheres. DENIZLI, A., SA1.111, B., and PISKIN, E., J. Chromatogr., A,. 1997, 773 (1 + 2), 169–178.
  • Novel microspheres for chemoembolization of liver metastases: experimental studies of Novikoff hepatoma in the rat. BAILTKowsKi, R., Kotn,Ea, H., BASTIAN, P., and Kisst.i., T., Langenhecks Arch. Chir. suppt. Kongresshd., 1997, 114, 319–323.
  • Novel cationic liposomes for DNA-transfection with high efficiency and low toxicity. PAUKK11, T., LAraAEus, S., HUEITANIENII, I., and KINNuNEN, P. K., Chem. Phys. Lipids,1997, 87 (1), 23–29. Novel proteinous microcapsules from wool keratins. YANIAUCIII, K., and KHODA, A., Colloids Surf., B, 9 (1/2), 117–119.
  • Oblique impact of microspheres with surfaces of known roughness. Li, X., DUNN, P. F., BRA( II, II. Ni., Zoo, X., and SNumt, G. L., Proc. Annu. Meet. Adhes. Soc., 20th, 215–217.
  • Obtaining pore size distributions within porous microspheres using stereological methods. ET IITEZAZ I, T., MELIA, C. D., and WASHINGTON, C., Proc. Int. Symp. C'ontrolled Release Rimier Mater., 1997, 24th, 629–630.
  • One-month controlled release of an antimicrobial peptide from biodegradable poly(lactide/ glycolide) microspheres for the treatment of periodontitis. JEYANTHI, R., AKIYANIA, A., ROBERTS, E. 1)., VAN IIA:\ioNT, J., and FainEN, P., Proc. Int. Symp. Controlled Release Bioact. Mater., 24th, 1997, 883–884.
  • Optimization of liposome mediated transfection of a neuronal cell line. NIcQL.0.1.1N, A., NIi.aaAy, K. D., ETHERIDGE, C. J., STEwART, L., CoPPER, R. G., BREYE, P. NI, NIiLLEit, A. D., and GiH. NI., Neuroreport, 1997, 8 (6), 1481–1484.
  • Oral administration of alginate microspheres stimulates pulmonary immunity in catttle. BmvERsock, 'I'. L., FloGENEscii, II.,WANii, B., ToarmatosA, S., RYIKER, D., PARK, H., RLEVINs, B., and PARK, K., Proc. Int. Symp. Controlled Release Broad. Mater., 1997, 24th, 149–150.
  • Oral delivery and fate of poly(lactic acid) microsphere-encapsulated interferon in rats. Evi,Es, J. E., Air a, II. 0., CoNwAv, B. R., and KiiswicK, NI., 3. Pharm. Pharmacol., 1997, 49 (7), 669–674.
  • Oral immunization with poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) micro-spheres containing pneumotropic bacterial antigens. KoEit, N., Rt-Fpi,, C., RiEsEit, C., WicK, G., and Wia.r, H., Int. Arch. Allergy Immunol., 1997, 113 (4), 424–431.
  • Oral delivery of microencapsulated proteins. Dim. sv, NI. D., and Moitim., E. NI., Pharm. Biotechnol., 1997, 10 (Protein Delivery), 255–288.
  • Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Ali.LEAN, J. \V., Fox, E. A., BAIAP., But.ToN, P. B., HAsKELL, A., PEARLMAN, R.,its.roN, G., UNIFAiirro, E. Y., and McDoNAID, D. M., Am. y. phythd., 1997, 273 (I Pt 2), H387–I1404.
  • Oxidation of rat liver phospholipids: comparison of pathways in homogeneous solution, in liposomal suspension and in whole tissue homogenates. KANIBAN'ASIII, Y., YAMASHITA, S., Nim, F., and Y‘AiAmirro,Biochton. (Tokyo), 1997, 121 (3), 425–431.
  • Oxprenolol release from bioadhesive gelatin/poly(acrylic acid) microspheres. LEt-c.t.TA, S. E., PoNcial., G., and Di cilENE, D., y. microeheapthiathhi, 1997, 14 (4), 511–522.
  • Perifollicular transgenic expression of human interleukin-1 receptor antagonist protein following topical application of novel liposome-plasmid DNA formulations in vivo. NIEAIII.V, S. M., CArl'A, J. NI., RA:mi. IIANDRAN, C., WEINER, N. D., and RoEssLER, B. J., y. pharm. Sci., 1997, 86 (6), 701–708.
  • Pharmacokinetic considerations in the development of labeled liposomes and micelles for diagnostic imaging. Tt)Ruint.IN, V. P., 0..7. A'uci. med., 1997, 41(2), 141–153.
  • Pharmacokinetic evaluation of liposomal encapsulated ampicillin in male and female rats. P HutR. L., and WHITE, C. A., Blopharm. Drug Dispos., 1997, 18 (4), 279–292.
  • Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients. MANN, V., BossE, D., JEliN, Ii., K 111NY, B., WAciiiiot.z, K., DEaus, A., Sulan.z, P., Kui.11, II. J., and WILAIANNs,Antinticrob. Agents Chemother., 1997, 41 (6), 1275–1280.
  • Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. IA t SAIN, D., NI0.1.F.R, J. NV., K.ENNry, A. G., MiciiAro, N.,T. J., and GaAimiinAs, F. S., Ophthalmology, 1997, 104 (8), 1242-1250.Photon tunneling from an optically manipulated microsphere to a surface by lasing spectral analysis. SAs \Kr, K., Fi'MVARA, H., and NI ssi ii \RA, H., Appl. Phys. Lett., 1997, 70 (20), 2647–2649.
  • Planar lipid bilayers on solid supports from liposomes—factors of importance for kinetics and stability. Puy, G., and GusTAFsoN, I., Biochim. Biophys. Ac/a, 1997, 1327 (2), 149–161. Plasma protein adsorption on biodegradable microspheres consisting of polyesters or ABA triblock copolymers. PisTia., K. F., ELF:LK,NIt'imi.lat, R. H., and Kissti,, T., Proc. Int.Symp. Controlled Release Bioact. Mater., 1997, 24th, 765–766.
  • Polyamide-610 microcapsules: Effect of organic phase. P[NERos, 1., B.m.rsTEHos, NI. P., and \s-rims, J. L., Proc. Int. Swap. Controlled Release Bioact. Mater., 1997, 24th, 985–986. Polyphosphazene microspheres for insulin release. C.:\ 1.1(yri, P., I.,()RA, S., and VtitoNEsE, F. NI., Proc. Int. Symp. Controlled Release Biotic. Mater., 1997, 24th, 509–510.
  • Porous dry-powder PLGA microspheres coated with lung surfactant for systemic insulin delivery via the lung. IIANF:S, J., 1-...,VoRA, G. E., BEN, JEBRIA, A., EnwAitos, D. A., and LANimi, E., Proc. Int. Symp. Controlled Release Broad. Mater., 1997, 24th, 57–58.
  • Porous poly(DL-lactic-co-glycolic acid) microsphere degradation and release of macromo-lecules. I I.kNi.s, J., II ii.t)(;FN, P., RATNVKV, R. P., C'I.H.ANI), J. F., Eimmtos, D. A., and L‘Nci.:ii, R., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 1027–1028.
  • Porous gelatin microsphere: a new tracer carrier. Liu, W., WANt;, J., 'bin), X., and Ji•, G., jiepou Xuehao, 1996, 27 (4), 445–446.
  • Preparation and subsequent degradation of poly(L-lactic acid) microspheres suitable for aerosolization: a physicochemical study. El. RASEIR, M. M., PHIPPS, NI. A., and KELLAwAy, I. W., Int. y. Pharm., 1997, 151(2), 145–153.
  • Preparation and evaluation of alginate microspheres containing norfloxacin and ciproflox-acin. Arnim., K. Sand Cures, N., Indian .7. Pharm. Ser., 1997, 59 (2), 61–67.
  • Preparation and evaluation of chitosan microspheres containing biphosphonates. PATASHNIK, S., RABINOVICH, L., and GOLOMB, G., J. Drug Targeting, 1997, 4 (6), 371–380.
  • Preparation and characterization of some biodegradable microspheres with antibiotics. MiRoN, M., DEMETER, F., PREDA, M., BODEA, A., and LEUCUTA, S. E., Farmacia (Bucharest), 1997, 45 (2), 37–44.
  • Preparation and stabilization of heparin/gelatin complex coacervate microcapsules. TSUNG, M., and BURGESS, D. J., J. Pharm. Sci., 1997, 86 (5), 603–607.
  • Preparation and characterization of poly(DL-lactic-co-glycolic acid) microspheres contain- ing desferrioxamine. SCULICHER, E. J. A. M., POSTMA, N. S., ZUIDEMA, J., TALSMA, H., and HENNINK, W. E., Int. y. Pharm., 1997, 153 (2), 235–245.
  • Preparation of agarose-poly(lactic-co-glycolic acid) microspherical composite for protein drug delivery. WANG, N., and Wu, X. S., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 959–960.
  • Preparation of hydrophobic and hydrophilic albumin microspheres and determination of surface carboxylic acid and amino residues. MACADANI, A. B., SHAFI, Z. B., JAMES, S. L., MARRIOTT, C., and MARTIN, G. P., Int. J. Pharm., 1997, 151 (1), 47–55.
  • Preparation of large colored microspheres with carboxyl groups for cell surface labeling. ZHAO, X., Liu, Y., and Hui, H., J. Med. Coll. PLA, 1997, 12 (1), 62–65.
  • Preparation of SrTiO3 ceramic foam from alkoxide-derived oxide green sheets containing polymer microspheres via polymer extraction. KAWASAKI, K., and OZAKI, Y., J. Ceram. Soc. jpn., 1997, 105, 600–605.
  • Preparation and evaluation of epirubicin-loaded gelatin microspheres. ACHIM, M., and LEUCUTA, S. E., Farmacia (Bucharest), 1997, 45 (2), 45–52.
  • Preparation of microcapsules using a spray dryer. YAMADA, N., Pharm. Tech. jpn., 1997, 13 (7), 1003–1012.
  • Preparation of protein-loaded poly(lactide-co-glycolide) microspheres using an ultrasonic atomizer. BITTNER, B., and KissEt., T., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 537–538.
  • Problems in the selection of microspherical cracking catalyst. GoNclimmv, S. V., SANIOKHVALOV, A. I., and LAPKIN, S. A., Ross. Khim. Zh., 1997, 41(1), 51–77.
  • Protein involvement in the fusion between the equatorial segment of acrosome-reacted human spermatozoa and liposomes. ARTS, E. G., WIJCHNIAN, J. G., JAGER, S., and HOEKSTRA, D., Biochem. y., 1997, 325 (Pt 1), 191–198.
  • Protein release from biodegradable microspheres prepared by spray drying can be modu-lated by monomer addition: effects of drug loading, drug distribution and mechanical properties of the polymer. BITTNER, B., and KissEt,, T., Ada Technol. Legis. Med., 1996, 7(3), 191–196.
  • Protein delivery from biodegradable microspheres. CLELAND, J. L., Pharm. Biotechnol., 1997, 10, 1–43.
  • Protein microspheres from water soluble polymers. BROWN, L. R., Buzz.-RD, C., RISKI•, F., ScoTT, T., and QIN, Y., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 1021–1022.
  • Protein release from poly(epsilon-caprolactone) mierospheres prepared by melt encapsula- tion and solvent evaporation techniques: a comparative study. J ANIEEIA, S. R., SUM.;, N., and JAYAKRISHNAN, A., J. Biomater. Sci. Polym. Ed., 1997, 81(6), 457–466.
  • Quantitative analysis of morphological change in biodegradable microspheres and its effect on protein release. PARK, T. G., and Cao-rrs, G., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 593–594.
  • Radiosensitization of glioblastoma after intracranial implantation of biodegradable 5-FU- loaded microspheres: phase 1 clinical trial. BENOIT, J. P., MENEI, P., VENIER, M. C., BO/SDRON, M., GAMFLIN, E., and GUY, G., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 995–996.
  • Reconstitution of FhuA, an Escherichia coli outer membrane protein, into liposomes. Binding of phage T5 to Fhua triggers the transfer of DNA into the proteoliposomes. PLANCCON, L., CHAMI, M., and LETELLIER, L., y. Biol. Chem., 1997, 272 (27), 16 868–16872.
  • Recovery of proteins from PLGA microspheres: use of cosolvents to dissolve both PLGA and proteins in a single aqueous phase. SAH, H., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 915–916.
  • Release of drug from microspheres adhered on animal mucosae. BOGATAJ, M., BURJAK, M., and ManAR, A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 1015-1016. Retention of trypsin activity in spermine alginate microcapsules. PATH., R. T., and SPEAKER, T. aL., J. Microencapsulation, 1997, 14 (4), 469–474.
  • Simultaneous measurement of liposome extravasation and content release in tumors. Wu, N. Z., BRAUN, R. D., GABER, M. H., LIN, G. M., Oro, E. T., SHAN, S., PAPAHADJOPOULOS, D., and DEwmasT, M. W., Microcirculation, 1997, 4 (1), 83–101.
  • Single and coencapsulation of interferon-y in biodegradable PLA microspheres for optimiza-tion of multicomponent vaccine delivery vehicles. CoNwAv, B. R., and ALI,AR, H. 0., Drug Delivery, 1997, 4 (2), 75–80.
  • Slow release of human epidermal growth factor from lactic acid oligomer microsphere. HviiN, S. Fl., WADA, R., and IKADA, Y., Proc. Int. Symp. Controlled Release &oriel. Mater., 1997, 24th, 887–888.
  • Sol-gel microsphere pelletization process for fabrication of (U, Pu) 02, (U, Pu)C and (U, Pu)N fuel pellets for the prototype fast breeder reactor in India. GANGULY, C., and HEDGE, P. V., J. Sol. Gel. Sci. Technol., 1997, 9 (3), 285–294.
  • Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres. Cirrci, K., HINCAI., A. A., KAS, H. S., ERCAN, T. M., NGIIR, A., GuvEN, 0., and RUACAN, S., Pharm. Der. Technol., 1997, 2 (2), 151-160. Solubilizing effects caused by the nonionic surfactant dodecylmaltoside in phosphatidyl-choline liposomes. DE LA MAZA, A., and PARRA, J. L., Biophys. .7., 1997, 72 (4), 1668-1675. Solute-induced shift of phase transition temperature in Di-saturated PC kiposomes: adoption of ripple phase creates osmotic stress. PERKINS, W. R., Li, X., SLATER, J. L., HAinioN, P. A., Ant., P. L., MINCHEY, S. R., GRUNER, S. M., and JANo, A. S., Biochim. Biophys. Ada, 1997, 1327 (1), 41–51.
  • Solvent effect on the moisture content of peptide drug for microencapsulation. G(-0, J. H., Proc. Int. symp. Controlled Release Bioact. Mater., 1997, 24th, 749–750.
  • Standardization of procedure for efficient ex vivo gene transfer into porcine pancreatic islets with cationic liposomes. BENHANIOU, P. Y., IVInRiscoT, C., PREvosT, P., R()I.LANn, E., HALL\ II, S., and CluvaioczEK, J., Transplantation, 1997, 63 (12), 1798–1803.
  • Stereospecific formulation and characterization of sustained release ibuprofen micro-spheres. JANJIKIIIM, R. K., and ADENT \-E, C. M., .7. Microencapsulation, 1997, 14 (4), 409–426.
  • Streptokinase entrapment in interdigitation-fusion liposomes improves thrombolysis in an experimental rabbit model. PERKINS, W. R., VAUGHAN, D. E., PLAviN, S. R., DALLY, W. L., RAUCH, J., LEE, L., and JANOFF, AS., Thromb. Haemost., 1997, 77 (6), 1174–1178.
  • Studies on preparation and characteristics of cisplatin chitosan microspheres. WANG, Y. M., Sul, '1'. S., Pt, Y. L., Ziit, J. G., and ZHAO, Y. L., Yao Hstteh Hsueh Pao, 1966, 31(4), 300–305.
  • Studies on the optimization of microsphere formulation for Yersinia pestis antigens for oral delivery: humoral and cellular responses. FALLS, J. E., ALPAR, H. 0., SHARP, G. J. E., and WILLIAmsoN, E. 1)., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 251–252.
  • Studies of sodium diclofenac release kinetics from microcapsules. Fa yros, P., PALomo, NI. E., II \ H.EsTERos, M. P., and Fin-ros, 0., Proc. Int., S'onp. Controlled Release Bioact. Mater., 1997, 24th, 351–352.
  • Study on the antigenicity of microencapsulated Sm28-GST from Schistosoma mansoni. Bi:Nori., M. A., Poul.AIN, 0()DEHt(n, 0., BARAs, 13., YOIIAN, B. B. C., RIVE \0., GILLARD, J., and CApRoN, A., Proc. Int. Symp. Controlled Release Biotic. Mater., 1997, 24th, 817–818.
  • Study on the production technology of microcapsule of ginger oleoresin. XIANG, Y., YANG, J., Li, G., WANG, L., and CHENG, M., Zhongguo Tiameipin, 1966, (9), 15–20.
  • Study of the interaction between tetanus toxoid and poly(lactic-co-glycolic acid) degrading microspheres. Tomo, M., and Ai.fiNs(), M. J., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 425–426.
  • Study on preparation of magnetic polymer microspheres-preparation and characterization of magnetic polymer microspheres containing -CHO group. Li, X., and St, N, Z., Lizi liaohuan Ii, Xiln, 1996, 12 (6), 486–492.
  • Study on microencapsulation process of Zanthoxylum oleoresin. XIANG, Y., YANG, J., Li, G., P., and Ciirn, M., Sichuan Daxue Xuebao, Ziran Kexueban., 1996, 33 (6), 760-764. Sustained local drug delivery to the arterial wall via biodegradable microspheres. DFv, V., EiGLER, N., FISIIBEIN, M. C., TIAN, Y., Hickm, A., RE04AviA, E., FORRESTER, J. S., and LIT\ v..K, F., Cathet. Cardiovasc. Diagn., 1997, 41(3), 324–332.
  • Sustained-release ketoprofen microspheres as dental pulp capping materials. VAL GlIAN, W. NI., Di ():\(:, H., and GlIOSII, T. K., Polon. Prepr. (Am. Chem, Soc. Div. Polon. ('hem), 1997, 38 (2), 612–613.
  • Synthesis and application of neoglycolipids for liposome modification. MIIRAHASIII, N., IsinnARA, II., SANAGANII, M., and SASAKI, A., Bio. Pharm. Bull., 1997, 20 (6), 704–707.
  • Synthesis of microspheres containing poly(acrylic acid) crosslinked with fl-cyclodextrin or maltose. BIBBY, D. C., DAviEs. N. M., and Tt cKER, I. G., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 545–546.
  • Synthesis of polystyrene microspheres by precipitation polymerization in polymer solution. Kim, Y. J., Kim, K. S., and Cn(), S. H., Pollimo, 1997, 21(3), 347–351.
  • Taxol microencapsulation into biodegradable uncapped poly(lactide-coglycolide) copoly-mers. \Took, N., VAN HA\ IONT, J., J:\COB, E., SETTERSTRO \ I, J., VAUGHAN, W., DUONG, H., aHoELANo, L., RAVIZEE, A., and Wool), B., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 881–882.
  • Tetracaine release from biodegradable microspheres. MARTINEZ, B., and NM:V(0110, M., Proc. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 595–596.
  • The effect of particle-matrix interfacial conditions on the compressive elasticity of epoxy resins filled with untreated hollow glass microspheres. PALumno, M. and TEMPEST I, E., Polym. Polym. Contpos., 5 (3), 217–221.
  • The polymer-alloys method as a new preparation method of biodegradable microspheres: principle and application to cisplatin-loaded microspheres. MATsL, NRY10, A., MATsl'i: \wA, Y., SUZUKI, T., YosluNo, H., and KoaAvAstit, M., Y. Controlled Release, 1997, 48 (1), 19–27.
  • The comparison of acute toxicity and antibacterial effect in vivo of amphotericin B micro- capsules and injections. HAN, W., HAN, Y., and Got, P., Huaxi Yaoxue Zazhi, 1997, 12 (2), 97–98.
  • The efficacy of doxorubicin microspheres for hepatic micrometastases in a rat tumor model. ESDALE, W. J., WALKER, T. L., WHITE, J., DEcauz, E. E., and BURTON, M. A., Clin. Exp. Metastasis, 1997, 15 (3), 239–245.
  • The heating of dye-doped polystyrene microspheres by ultraviolet radiation of N2 laser. AsTAE-EvA, L. G., and LEDNEVA, G. P., High Temp. (Transl. of Teplofiz. Vys Temp.), 1997, 35 (3), 451–454.
  • The lymphatic pathways, and regional lymph nodes of the rat liver visualized of liposomes and fluorochrome—labelled dextran. KosiEwicz, J., MiKusEk, J., Zaa.ko, E., and GAIMYS, J., Folio. Morphol. (Warsz), 1996, 55 (4), 343–344.
  • The modified solvent extraction method on the preparation of poly(L-lactic acid) micro- spheres. KIM, J. H., KwoN, 1. C., Kii, Y. H., Soo x, Y. T., and JEoNG, S. Y., Prot-. Int. Symp. Controlled Release Bioact. Mater., 1997, 24th, 549–550.
  • The possible role of clay mineralogy in the study of microspherules of cosmic origin. ViuziAN, 1., Acta Mineral. Petrogr., 1996, 37, 35–40.
  • The role of surface hydrophobicity in the transport of polystyrene microspheres through Caco-3 cell monolayers and intestinal mucin. Nowt's, D. A., and StNko, P. J., Proc. Int. Svnzp. Controlled Release Bioact. Mater., 1997, 24th, 17–18.
  • The stabilization and encapsulation of human growth hormone into biodegradable micro- spheres. JOHNSON, 0. L., JAWORDWICZ, W., CLELAND, J. L., BAILEY, L., CHARMS, NI., DITNAS, E., Wu, C., SHEPARD, D., Mmal., S., LAST, 'F., JONES, A. J., and PUTNEY, S. D., Pharm, Res., 1997, 14 (6), 730–735.
  • Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth lipo- somes against Mycobacterium tuberculosis infection induced in mice. DEm., P., KiluLLER, G. K., and Jositi, K., Antimicrob. Agents Chemother., 1997, 41(6), 1211–1214.
  • Thermal decomposition of polystyrene in the high temperature fabrication technology of hollow microspheres. DoamarrovEsEv, V. M., AKUNETS, A. A., MEakumv, Y. A., 'FultivNov, A. P., RE:113mo, R., FEARON, E., and Cook, R., Fusion Technol., 1997, 31 (4), 424–430.
  • Thermodynamics to improve microencapsulation by PLA coacervation: process control and residual solvents. GANDER, B., TnnmAsiN, C., NAN', T. H., and MERKI,E, H. P., Proc. Int. S'yntp. Controlled Release Bioact. Mater., 1997, 24th, 130–131.
  • Treating STZ-induced diabetic rats with agarose microcapsulated porcine islets. Yu, D., YIN, NV., and Wu, R., Chung Hull I Hsueh Tsa Chill, 1996, 76 (5), 367–370.
  • Treatment of visceral leishmaniasis with a 10 day course of L-ampB-LRC (Bombay), a liposomal amphotericin B. Boom, P. V., PA'I'llARE, A. V., KSIIIRSAGAR, N. A., and PANDr.\, S. K., y. Assoc. Physicians India, 1996, 44 (3), 222.
  • Triboelectric charge control of polymer microspheres by low-temperature plasma treat- ments. hicui, K., UEMURA, Y., YosulizAwA, H., 1-I r ATE, V., HARAGUCIII, T., IDE, S., HATAN \KA, C., 1'Am:um, K., and KAwANo, V. Kagaku Kogaku Ronbunshu, 1997, 23 (4), 578–581.
  • Trilayer composite poly(styrene/butyl acrylate/acrylic acid) terpolymer microspheres with Fe203 middle layer: synthesis and characterization. Du, H., ZHANc, P., Liu, F., KAN, S., WANG, D., Li, T., and TANG, X., Polym. Int., 1997, 43 (3), 274–280.
  • Upscaling the production of microencapsulated pancreatic islets. DE Vos, P., DE HAAN, B. J., and VAN SCHILFGAIRDE, R., Bionzaterials, 1997, 18 (16), 1085–1090.
  • Uptake of charged liposomes by the rat liver. Yu, H. V., and LIN, C. Y., 1. Formos. Med. Assoc., 1997, 96 (6), 409–413.
  • Use of enteric polymers for production of microspheres by extrusion-spheronization. VAasnosiz, J., KENNEDY, R. A., and GIPPS, E. NI., Pharm. Ada. Heir., 1997, 72 (3), 145–152.
  • Validation of the multiple colored microsphere technique for regional blood flow measure- ments in newborn piglets. WALTER, B., BAUER, R., GASER, E., and ZWIENER, U., Basic Res. Cardiol., 1997, 92 (3), 191–200.
  • Variation of droplet sizes during the formation of microcapsules from emulsions. Oyu, B., CITAK, B., ()/.11.mEt., D., BALMS, A., PEKFR, S., and CAKIR, S., J. MiCrOer/CCIPS/datiOn, 1997, 14 (4), 489–499.
  • Visualized dynamics of microtubules and liposomes. KANEKO, T., TANAKA, V., and 1-10TAN1, H., Tanpakusititsu Kakusan Koso, 1997, 42 (7 Suppl), 1215-1220. X-ray photoelectrron spectroscopy (XPS) surface analysis of HEMA-MMA microcapsules. HARENsrE, J. E., Sonin, R. N. S., and SEFTON, M. V., y. Biomater. Sci. Polym. Ed., 1997, 8 (9), 655–665.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.